In the press

2026

“New Clinical Data Move Cabaletta Closer to First Autoimmune CAR-T Approval”
Penn Center for Innovation, Jul 2026

“A Primer on CAR T Cell Therapy”
Myasthenia Gravis Foundation of America, Jul 2026

“Meet Our Board of Trustees”
Advancing Innovation in Dermatology, Feb 2026

2021

2018

“Pemphigus remission rate tops 80% with rituximab”
Dermatology News, Jun 2018

2016

“Modulating Immunity to Treat Autoimmune Disease”
New England Journal of Medicine, Oct 2016

“Engineering the Immune System to Correct Its Own Flaws”
PemPress, Sep 2016

“Precision medicine for autoimmune disease”
Nature Biotechnology, Sep 2016

“Like Angler Fish, CAARs Lure Their Prey”
Molecular Therapy, Aug 2016

“Approach targets autoimmunity”
NIH Research Matters, Jul 2016

“‘Civil war’ in immune system can fight disease”
BBC, Jul 2016

“Fighting autoimmunity with immune cells”
Science, Jul 2016

2014

“A New Light on an Old Disease: Adhesion Signaling in Pemphigus Vulgaris”
Journal of Investigative Dermatology, Jan 2014

​Lab shipping address:
Russ Berrie Medical Science Pavilion
1150 St. Nicholas Avenue
3rd Floor, Room 315
New York, NY 10032
​212-851-4800
Clinical Office:
161 Fort Washington Avenue
12-1214 Herbert Irving Pavilion
New York, NY 10032
​212-305-5665